Clinical Trials · NCT03182426
Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Alberta
- Enrollment
- 22
- Start date
- Aug 2017
- Locations
- 1 site, Canada
- Primary endpoint
- Change of 2-hour mixed meal stimulated C-peptide AUC